https://cubabusinessreport.com/abdala-vaccine-shows-92-28-efficacy-after-phase-iii-trial/
ABDALA Vaccine Shows 92.28% Efficacy After Phase III Trial -
Feb 3, 2022 - Scientist Marta Ayala has just informed Cuban President Miguel Diaz-Canel the ABDALA vaccine shows 92.28% efficacy in phase III trials with...
phase iii trialabdala vaccineshowsefficacy